Exclusive: Two powerful Canadian provinces argued against federal drug price crackdown

Canada's two most populous provinces, Ontario and Quebec, have privately expressed concerns with a federal government plan to slash the price of patented drugs, arguing that such regulatory changes could hurt investment in life sciences.